Blog

Patrick Forde: Presented data on adjuvant immunotherapy at WCLC2024 to help guide management of lung cancer

Photo of Patrick Forde/facebook

Sep 14, 2024, 06:23

Patrick Forde: Presented data on adjuvant immunotherapy at WCLC2024 to help guide management of lung cancer

Patrick Forde, Professor at the Johns Hopkins University, posted the following on LinkedIn:

“In the presidential session at the World Conference on Lung Cancer today, WCLC2024, I presented data to help guide use of adjuvant immunotherapy after neoadjuvant chemo-immunotherapy for lung cancer. This is a key clinical question in management of lung cancer, and these data may help guide management in near future.”

Source: Patrick Forde/LinkedIn

adjuvant immunotherapy cancer Cancer Management Cancer research clinical data immunotherapy Johns Hopkins University Lung cancer lung cancer treatment neoadjuvant chemo-immunotherapy OncoDaily Oncology Patrick Forde WCLC2024 World Conference on Lung Cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage